Pakistan Institute of Living and Learning
pill.org.pkTotal trials
58
Active
19
Phase 3
2
Total enrollment
42,689
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Standardised pharmacological treatment | — | — | — | — | — | 1 |
Next readouts
- 2028-12-30
Top conditions
- Depression10
- Psychosis7
- Schizophrenia6
- Schizoaffective Disorder6
- Maternal Depression5
- Self Harm5
- Suicidal Ideation4
- Schizophreniform Disorder4
Frequently asked questions about Pakistan Institute of Living and Learning
- How many clinical trials does Pakistan Institute of Living and Learning have on ClinicalTrials.gov?
- Pakistan Institute of Living and Learning is listed as the lead sponsor on 58 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Pakistan Institute of Living and Learning's trials are in Phase 3?
- 2 of Pakistan Institute of Living and Learning's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Pakistan Institute of Living and Learning focus on?
- Pakistan Institute of Living and Learning's most-studied conditions on ClinicalTrials.gov are Depression, Psychosis, Schizophrenia, Schizoaffective Disorder, Maternal Depression.
- When are Pakistan Institute of Living and Learning's next clinical trial readouts?
- Pakistan Institute of Living and Learning has 1 upcoming primary-completion readout tracked here; the soonest is “Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan”, expected around 2028-12-30.